Bit.bio develops a cell coding platform that utilizes deterministic programming to create and manufacture any human cell type with precision and scalability. This technology addresses the need for consistent and reliable cell production for research and therapeutic applications, enabling the development of next-generation treatments.
Funding
$214.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MGFounders
Product
Problem
The inconsistency and lack of scalability in traditional cell production methods hinder research and therapeutic development, leading to unreliable results and high costs. Generating specific human cell types with precision and at scale remains a significant challenge for biomedical applications.
Solution
Bit.bio offers a cell coding platform that uses deterministic programming to precisely create and manufacture human cells at scale. Their opti-ox™ technology enables controlled gene expression, allowing for rapid and consistent conversion of induced pluripotent stem cells (iPSCs) into specific human cell types. This technology addresses the need for consistent and scalable cell production, providing researchers and drug developers with reliable, off-the-shelf human cell models. The resulting ioCells™ are designed for research, drug discovery, and cell-based therapies, offering functionality, consistency, and scalability.
Target Audience
The primary target audience includes researchers in academia and industry, drug discovery companies, and cell therapy developers seeking consistent, scalable, and functional human cell models.
Features
- opti-ox™ technology for deterministic forward programming of pluripotent stem cells (PSCs)
- Dual genomic safe harbor (GSH) approach for controlled gene expression
- Capability to create any human cell type and manufacture it at scale
- ioCells™ product line including wild-type cells, disease model cells, CRISPR-ready cells, and tracker cells
- Custom cell development services available
- Extensive protocol library for cell culture, characterization, and assays
- Multi-cell culture protocols for co-culturing different ioCell types